Here are what the editors at HealthDay consider to be the most important developments in Pain Management for October 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Opioid Use Often Persists in Workers’ Compensation Claimants
WEDNESDAY, Oct. 31, 2018 (HealthDay News) — Many patients in a workers’ compensation cohort have persistent opioid use, according to a study published online Oct. 26 in JAMA Network Open.
AMA Announces Initiative to Reinvent Physician Training
TUESDAY, Oct. 30, 2018 (HealthDay News) — The American Medical Association (AMA) today announced a new $15 million competitive grant initiative, the “Reimagining Residency” initiative, aimed at improving residency training.
Many Hospitals Noncompliant With Record Request Regulations
MONDAY, Oct. 29, 2018 (HealthDay News) — Among top-ranked U.S. hospitals, data reveal discrepancies in information provided to patients regarding medical records release processes as well as noncompliance with state and federal regulations, according to a study published online Oct. 5 in JAMA Network Open.
Trump Administration Announces Plan to Cut Drug Prices
FRIDAY, Oct. 26, 2018 (HealthDay News) — In an effort to cut high drug costs, the prices paid by Medicare for certain prescription drugs would be based on those in other advanced industrial nations, according to a proposal announced Oct. 25 by the Trump administration.
HHS Study
New York Times Article
Open Surgery for Early Lung CA Tied to Long-Term Opioid Use
THURSDAY, Oct. 25, 2018 (HealthDay News) — Surgical invasiveness might play a role in the odds of becoming a long-term opioid user after early-stage lung cancer surgery, according to a research letter published online Sept. 24 in JAMA Oncology.
Pace of Change Has Accelerated in Alternative Payment Models
THURSDAY, Oct. 25, 2018 (HealthDay News) — The impact of alternative payment models (APMs) on physician practices has been described in a study published by the RAND Corp. and the American Medical Association.
Most Supplements Contain Prohibited Stimulants
WEDNESDAY, Oct. 24, 2018 (HealthDay News) — Many supplements contain one or more stimulants that have been the subject of U.S. Food and Drug Administration-issued public notices, according to a research letter published online Oct. 22 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Editor’s Note (subscription or payment may be required)
White House Unveils New Insurance Option for Small Firms
TUESDAY, Oct. 23, 2018 (HealthDay News) — A plan to allow small businesses to use tax-free accounts to provide health coverage for employees was announced today by the Trump administration.
AP News Article
More Information
Postnatal Education Increases Pain Relief Use at Vaccinations
People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users 
CDC: Buprenorphine Treatment Differs in Urban, Rural Areas 
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus 
Botox Helpful in Alleviating Chronic Migraine in Pediatric Patients 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Updated Recommendations Address Medications to Prevent Migraine in Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens 
.jpg)